| Name: | Montelukast EP Impurity A |
| Catalogue No. | VL510005 |
| CAS No. | 220927-27-5 |
| Molecular Formula | C35H35ClNO3S |
| Molecular Weight | 586.18 |
| Status | In-stock |
| IUPAC Name | 1-[[[(1S)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid |
| Synonyms | Montelukast S-Isomer Impurity |
| Description | Montelukast EP Impurity A (CAS No: 220927-27-5) or Montelukast S-isomer Impurity is an impurity present in montelukast which is utilized as one of the selective antagonists of leukotriene receptor. It could reduce inflammatory reactions mediated by leukotrienes, lower blood pressure. |
| References | Barnabas, K. Samuel, et al. “A Novel Stability-Indicating Method for Determination of Related Substances of Montelukast Sodium in a Pharmaceutical Dosage Form Using RP-HPLC.” Chromatographia, vol. 84, no. 7, June 2021, pp. 645–62, https://doi.org/10.1007/s10337-021-04045-8. Wang, D. “Simultaneous Determination of Montelukast Sodium S-Enantiomer and A5 Enantiomers in Montelukast Sodium Bulk Drug by Normal-Phase Chiral HPLC.” Indian Journal of Pharmaceutical Sciences, vol. 79, no. 01, 2017, http |
